Proliferating CLL cells express high levels of CXCR4 and CD5
2024

Proliferating CLL Cells Express High Levels of CXCR4 and CD5

Sample size: 20 publication 10 minutes Evidence: high

Author Information

Author(s): Daniel Friedman, Drshika P. Mehtani, Jennifer B. Vidler, Piers E. M. Patten, Robbert Hoogeboom

Primary Institution: King's College London

Hypothesis

The study aims to identify and characterize the phenotype and functional characteristics of proliferating CLL cells.

Conclusion

The study identifies a novel subclonal population of CLL cells that may drive clinical outcomes and disease progression.

Supporting Evidence

  • Proliferating CLL cells in the blood express high levels of CXCR4 and CD5.
  • CXCR4hiCD5hi cells are enriched for highly proliferative cells upon stimulation.
  • An expanded CXCR4hiCD5hi fraction in tissue may reflect enhanced proliferation rates.
  • CXCR4 and CD5 levels are higher in patients with progressive disease.
  • CXCR4hiCD5hi cells express increased levels of chemokine receptors and migrate efficiently.

Takeaway

This study found that certain leukemia cells are very active and have specific markers that help them grow and move in the body.

Methodology

The study used flow cytometry to analyze peripheral blood samples from CLL patients, assessing cell cycle phases and surface marker expression.

Limitations

The study may not fully capture all cell states among circulating CLL cells.

Participant Demographics

Patients with chronic lymphocytic leukemia (CLL), including both unmutated and mutated IGHV cases.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/hem3.70064

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication